Pfizer and BioNTech has submitted an application to the US Food and Drug Administration (FDA) for emergency use authorization of the Omicron-adapted COVID-19 vaccine booster for children under 5 years. If the vaccine is authorized, the children would receive the primary series of the vaccine consisting of two doses of the original COVID-19 vaccine developed […]
Continue Reading
Pfizer is dropping one of the assets it picked up in the takeover of Array Bio Pharma, worth 11.4 billion dollars three years ago. After carrying out a phase 3 interim futility analysis, Big Pharma has decided to stop working on the cardiovascular disease candidate PF-07265803. With Array BioPharma kicking it off in 2018, Pfizer […]
Continue Reading
The Director-General of the UN World Health Organization (WHO), Tedros Adhanom Ghebreyesus, has called on Pfizer to do more to make sure that its new Covid-19 oral antiviral drug is available quickly to provide effective treatment to countries that might struggle to afford the medicine. This appeal comes as confirmed Covid-19 cases has increased by […]
Continue Reading
On Wednesday, 25th May 2022, Pfizer said, riding high on the unprecedented success of the company’s corona virus that is going to be making 23 of its medicines and most of them have been patented and will be available for 45 of the low-income countries at the manufacturing price. Pfizer has now revealed the initiative, […]
Continue Reading
Pfizer Inc. said it is going to be purchasing the Biohaven Pharmaceutical Holding Co. for a sum of 11.6 billion dollars in cash for the purpose of gaining an approved treatment for the migraine headaches. Pfizer is also going to pay 148.50 dollars a share for all of the New Haven, which is a Connecticut-based […]
Continue Reading
Pfizer and BioNTech announced the positive results from the clinical trial that were conducted on the safety and immune response of a third dose of the novel corona virus vaccine in the children between the age of 5 to 11 years and the companies also added that, they are soon going to be seeking the […]
Continue Reading
Pfizer Inc., has now agreed for purchasing the respiratory antiviral drug producing company ‘ReViral Ltd.’ For a sum of 525 million dollars as the latest move of the company in the one-time overlooked field of the infectious disease. The company ‘ReViral Ltd.’ Based in the United Kingdom has been developing the therapies for the respiratory […]
Continue Reading
As the corona virus vaccine developed by Pfizer and BioNTech have become available in October 2021 for the children coming in the age group of 5 to 11 years old, and most of the parents have been hesitant for having them vaccinated. On March 16 2022, only 27 percent had now received two corona virus […]
Continue Reading
Albert Bourla, chief executive officer of Pfizer said, the company is soon going to be submitting the data to the regulators of the United States on a fourth dose of the novel corona virus vaccine. He also said that, the new data from the different studies of the corona virus including the one focusing at […]
Continue Reading
According to new study conducted by the Centers for Disease Control and Prevention (CDC) of the United States said that, the efficacy of the third doses or booster doses of the Pfizer and Moderna mRNA covid-19 vaccines wanes by the fourth month after the vaccination substantially. Although it has now been well documented that, the […]
Continue Reading